A detailed history of Jpmorgan Chase & CO transactions in Rapid Micro Biosystems, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 573,928 shares of RPID stock, worth $619,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
573,928
Previous 622,831 7.85%
Holding current value
$619,842
Previous $604,000 37.42%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.66 - $1.0 $32,275 - $48,903
-48,903 Reduced 7.85%
573,928 $378,000
Q1 2024

May 10, 2024

SELL
$0.9 - $1.1 $115,632 - $141,329
-128,481 Reduced 17.1%
622,831 $604,000
Q4 2023

Feb 12, 2024

SELL
$0.74 - $1.17 $505,357 - $799,011
-682,916 Reduced 47.62%
751,312 $555,000
Q3 2023

Nov 14, 2023

SELL
$0.89 - $1.18 $1,316 - $1,745
-1,479 Reduced 0.1%
1,434,228 $1.55 Million
Q2 2023

Aug 11, 2023

SELL
$0.83 - $1.37 $16,146 - $26,651
-19,454 Reduced 1.34%
1,435,707 $1.44 Million
Q1 2023

May 11, 2023

BUY
$1.06 - $1.5 $1.54 Million - $2.18 Million
1,453,885 Added 113940.83%
1,455,161 $1.91 Million
Q4 2022

Feb 13, 2023

SELL
$1.13 - $3.5 $1.6 Million - $4.95 Million
-1,414,867 Reduced 99.91%
1,276 $1,000
Q3 2022

Nov 14, 2022

SELL
$2.95 - $4.66 $191,136 - $301,930
-64,792 Reduced 4.38%
1,416,143 $4.57 Million
Q2 2022

Aug 11, 2022

SELL
$2.49 - $6.76 $397,573 - $1.08 Million
-159,668 Reduced 9.73%
1,480,935 $6.37 Million
Q1 2022

May 11, 2022

SELL
$5.76 - $10.83 $836,179 - $1.57 Million
-145,170 Reduced 8.13%
1,640,603 $11.1 Million
Q4 2021

Feb 10, 2022

BUY
$9.41 - $22.19 $955,500 - $2.25 Million
101,541 Added 6.03%
1,785,773 $19 Million
Q3 2021

Nov 12, 2021

BUY
$17.88 - $24.8 $30.1 Million - $41.8 Million
1,684,232 New
1,684,232 $31.1 Million

Others Institutions Holding RPID

About RAPID MICRO BIOSYSTEMS, INC.


  • Ticker RPID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,389,100
  • Market Cap $39.3M
  • Description
  • Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumab...
More about RPID
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.